Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Etoposide × CNS × Clear all

Phase

Status

Completed 81 Unknown 17 Recruiting 12 Terminated 10 Active not recruiting 9 Withdrawn 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 19 Sarcoma 2 Other solid neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1 CNS 1

Conditions

Medulloblastoma 1 Ependymoma 1

Interventions

Temozolomide 20 Magnetic Resonance Spectroscopy 9 Radiotherapy 8 Blood Specimen Collection 8 Cyclophosphamide 6 AZD 6244 6 pembrolizumab 5 Bevacizumab 5 Specimen Handling 4 Radiation 4 Nivolumab 4 fludarabine 3 dinutuximab 3 aflutinib 3 Surgical Procedures, Operative 3 Saline Solution 3 Pemetrexed 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Biopsy 3 vorasidenib 2 tovorafenib 2 tislelizumab 2 osimertinib 2 naxitamab 2 gallium maltolate 2 fludarabine phosphate 2 Topotecan 2 Surveys and Questionnaires 2 Spinal Puncture 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06485908 2024-07-03

MEPENDAX

Assistance Publique Hopitaux De Marseille

Phase 1/2 Not yet recruiting

Ependymoma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡